Kardigan, Inc. (KARD) Executive Compensation
Kardigan, Inc. (KARD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KARD
CIK: 2123613
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerGreg Vlahos
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-01 | 2026-09-29 | 4 | 0001193125-26-410930 | View SEC Doc Filr Page |
| 3 | 2026-10-01 | 2026-09-29 | 3 | 0001193125-26-410926 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-10-01 | — | SCHEDULE 13D/A Filing | 0001193125-26-410754 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-29 | 8-K | 0001193125-26-408348 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001193125-26-349822 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001193125-26-349746 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343418 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343395 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0000315066-26-002254 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002193 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-06-17 | 4 | 0001193125-26-302095 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-29 | — | SCHEDULE 13G Filing | 0001193125-26-288926 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-06-29 | — | SCHEDULE 13D Filing | 0001193125-26-288406 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-06-25 | — | SCHEDULE 13D Filing | 0001193125-26-282713 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 | 0001193125-26-281553 | View SEC Doc Filr Page |
| 3/A | 2026-06-24 | 2026-06-17 | 3/A | 0001193125-26-281548 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000565 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000564 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-22 | 8-K | 0001193125-26-278429 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 | 0001193125-26-278251 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 | 0001193125-26-277985 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 | 0001193125-26-277955 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 | 0001193125-26-277950 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 | 0001193125-26-277936 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 | 0001193125-26-277933 | View SEC Doc Filr Page |